Literature DB >> 32867489

Bis(sulfosuccinimidyl)suberate-Based Helix-Shaped Microchannels as Enhancers of Biomolecule Isolation from Liquid Biopsies.

Choong Eun Jin1, Bonhan Koo1, Hyo Joo Lee1, In Ja Park2, Sung-Han Kim3, Yong Shin1.   

Abstract

Most studies of ultrasensitive diagnosis of biomolecules from liquid specimens are limited by problems during sample preparation steps, including enrichment and isolation of biomolecules. Here we report a novel platform combining bis(sulfosuccinimidyl)suberate (BS3) and helix-shaped microchannels (BSH) to change the sample preparation paradigm. This BSH system is composed of BS3 for pathogen enrichment and nucleic acid isolation by electrostatic and covalent interaction, and helix-shaped microchannels to minimize sample loss and remove bubbles in large liquid specimens without pH change. The system detected Mycobacterium tuberculosis following enrichment and isolation of 10 mL of liquefied sputum from 11 patients with tuberculosis. Moreover, the system identified KRAS mutations following cell-free DNA isolation of blood plasma from 10 patients with colorectal cancer. This system allows ultrasensitive diagnosis in various disease applications with large volumes of liquid samples.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32867489     DOI: 10.1021/acs.analchem.0c02503

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  2 in total

1.  Gene-Based Diagnosis of Tuberculosis from Oral Swabs with a New Generation Pathogen Enrichment Technique.

Authors:  Young Ae Kang; Bonhan Koo; Yong Shin; Sei Won Lee; Ock-Hwa Kim; Joung Ha Park; Ho Cheol Kim; Hyo Joo Lee; Myoung Gyu Kim; Youngwon Jang; Na Hyun Kim; Yong Seo Koo; Sung-Han Kim
Journal:  Microbiol Spectr       Date:  2022-05-19

Review 2.  Recent Advances in Device Engineering and Computational Analysis for Characterization of Cell-Released Cancer Biomarkers.

Authors:  Hesam Abouali; Seied Ali Hosseini; Emma Purcell; Sunitha Nagrath; Mahla Poudineh
Journal:  Cancers (Basel)       Date:  2022-01-07       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.